These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18416789)

  • 1. A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings.
    Baker JA; Lovell K; Harris N
    J Clin Nurs; 2008 May; 17(9):1122-31. PubMed ID: 18416789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study.
    Baker JA; Lovell K; Harris N
    Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary consensus of best practice for pro re nata (PRN) psychotropic medications within acute mental health settings: a Delphi study.
    Baker JA; Lovell K; Harris N; Campbell M
    J Psychiatr Ment Health Nurs; 2007 Aug; 14(5):478-84. PubMed ID: 17635256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of pro re nata medications in acute inpatient care.
    Stein-Parbury J; Reid K; Smith N; Mouhanna D; Lamont F
    Aust N Z J Psychiatry; 2008 Apr; 42(4):283-92. PubMed ID: 18330770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health professionals' psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: a qualitative study.
    Baker JA; Lovell K; Harris N
    Gen Hosp Psychiatry; 2007; 29(2):163-8. PubMed ID: 17336666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical decision-making for 'as needed' medications in mental health care.
    Usher K; Baker JA; Holmes C; Stocks B
    J Adv Nurs; 2009 May; 65(5):981-91. PubMed ID: 19291187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic PRN use among older people's inpatient mental health services.
    Baker JA; Keady J; Hardman P; Kay J; Jones L; Jolley D
    J Psychiatr Ment Health Nurs; 2010 Jun; 17(5):463-8. PubMed ID: 20584243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRN psychotropic medication and acute mental health nursing: reviewing the evidence.
    Molloy L; Field J; Beckett P; Holmes D
    J Psychosoc Nurs Ment Health Serv; 2012 Aug; 50(8):12-5. PubMed ID: 22801821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of evidence that the pro re nata regimen confers benefit: a review of the studies.
    Yoshida K; Suzuki T; Uchida H; Mimura M
    Int Clin Psychopharmacol; 2013 Sep; 28(5):228-37. PubMed ID: 23727905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of therapeutic interventions that accompany the administration of p.r.n. ('as required') psychotropic medication within acute mental health settings: a retrospective study.
    Curtis J; Baker JA; Reid AR
    Int J Ment Health Nurs; 2007 Oct; 16(5):318-26. PubMed ID: 17845551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of PRN medications and use of nonpharmacologic interventions in acute geropsychiatric settings: implications for practice.
    Lindsey PL; Buckwalter KC
    J Am Psychiatr Nurses Assoc; 2012; 18(2):82-90. PubMed ID: 22442015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro re nata use in a psychiatric intensive care unit.
    Mullen A; Drinkwater V
    Int J Ment Health Nurs; 2011 Dec; 20(6):409-17. PubMed ID: 21564456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
    Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding clinical decision making for PRN medication in mental health inpatient facilities.
    Usher K; Baker JA; Holmes CA
    J Psychiatr Ment Health Nurs; 2010 Aug; 17(6):558-64. PubMed ID: 20633084
    [No Abstract]   [Full Text] [Related]  

  • 16. Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital.
    Martin K; Arora V; Fischler I; Tremblay R
    Int J Ment Health Nurs; 2017 Aug; 26(4):402-408. PubMed ID: 27804222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wards features associated with high rates of medication refusal by patients: a large multi-centred survey.
    Baker JA; Bowers L; Owiti JA
    Gen Hosp Psychiatry; 2009; 31(1):80-9. PubMed ID: 19134514
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Saito E; Eng S; Grosso C; Ozinci Z; Van Meter A
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):250-260. PubMed ID: 31800304
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of non-pharmacological interventions attempted prior to pro re nata medication use.
    Martin K; Arora V; Fischler I; Tremblay R
    Int J Ment Health Nurs; 2018 Feb; 27(1):296-302. PubMed ID: 28247580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Documentation of psychotropic pro re nata medication administration: An evaluation of electronic health records compared with paper charts and verbal reports.
    Martin K; Ham E; Hilton NZ
    J Clin Nurs; 2018 Aug; 27(15-16):3171-3178. PubMed ID: 29752835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.